![Pat Costello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pat Costello
Director/Miembro de la Junta en Alucent Biomedical Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Myles D. Greenberg | M | 56 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
James Corbett | M | 65 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Daniel Pelak | M | 72 |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | 6 años |
David Flicek | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Ryan Hansen | M | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Julie Lautt | F | - |
Alucent Biomedical Inc.
![]() Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 6 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Pat Costello
- Red Personal